First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease.

Item Type:

Publication

Title

First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease.

Description

A neonate born to an Ebola virus-positive woman was diagnosed with Ebola virus infection on her first day of life.

Date Last Updated (Year-Month-Day)

2017-01-15

Citation

Dörnemann, Jenny, Chiara Burzio, Axelle Ronsse, Armand Sprecher, Hilde De Clerck, Michel Van Herp, Marie-Claire Kolié, Vesselina Yosifiva, Severine Caluwaerts, Anita K. McElroy, and Annick Antierens. 2017. "First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease." The Journal of infectious diseases 215 (2):171-4.

Abstract

A neonate born to an Ebola virus-positive woman was diagnosed with Ebola virus infection on her first day of life. The patient was treated with monoclonal antibodies (ZMapp), a buffy coat transfusion from an Ebola survivor, and the broad-spectrum antiviral GS-5734. On day 20, a venous blood specimen tested negative for Ebola virus by quantitative reverse-transcription polymerase chain reaction. The patient was discharged in good health on day 33 of life. Further follow-up consultations showed age-appropriate weight gain and neurodevelopment at the age of 12 months. This patient is the first neonate documented to have survived congenital infection with Ebola virus.

Accessibility

free on Pubmed

Document Viewer

Share this page: